NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,573.41 +366.28 (+2.01%) CRUDE OIL
79.18 +0.23 (+0.29%) GOLD FUTURES
2,314.90 +5.30 (+0.23%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,353.25 +1,841.46 (+4.05%)
Accelerate Diagnostics Inc. (1A80.SG)
| Previous close | 0.8150 |
| Open | 0.8550 |
| Bid | 0.8150 x N/A |
| Ask | 0.9000 x N/A |
| Day's range | 0.8200 - 0.8650 |
| 52-week range | 0.6800 - 9.1000 |
| Volume | |
| Avg. volume | 80 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksWill Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review 2024 first quarter results.
Insider MonkeyAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript March 28, 2024 Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and […]
